DB:UPH

Stock Analysis Report

U.S. Physical Therapy

Executive Summary

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Snowflake

Fundamentals

Excellent balance sheet with solid track record.


Similar Companies

Share Price & News

How has U.S. Physical Therapy's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: UPH's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

1.0%

UPH

1.0%

DE Healthcare

-0.3%

DE Market


1 Year Return

6.1%

UPH

-2.6%

DE Healthcare

10.9%

DE Market

Return vs Industry: UPH exceeded the German Healthcare industry which returned -2.6% over the past year.

Return vs Market: UPH underperformed the German Market which returned 10.9% over the past year.


Shareholder returns

UPHIndustryMarket
7 Day1.0%1.0%-0.3%
30 Day-16.0%11.6%2.6%
90 Day-13.7%7.8%11.8%
1 Year7.1%6.1%-0.9%-2.6%14.4%10.9%
3 Year83.3%77.5%-17.9%-20.9%24.1%13.2%
5 Year257.0%237.7%16.2%9.7%33.0%14.8%

Price Volatility Vs. Market

How volatile is U.S. Physical Therapy's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is U.S. Physical Therapy undervalued compared to its fair value and its price relative to the market?

49.91x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: UPH (€105) is trading above our estimate of fair value (€97.29)

Significantly Below Fair Value: UPH is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: UPH is poor value based on its PE Ratio (49.9x) compared to the Healthcare industry average (32.3x).

PE vs Market: UPH is poor value based on its PE Ratio (49.9x) compared to the German market (19.9x).


Price to Earnings Growth Ratio

PEG Ratio: UPH is poor value based on its PEG Ratio (3.3x)


Price to Book Ratio

PB vs Industry: UPH is overvalued based on its PB Ratio (6.3x) compared to the DE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is U.S. Physical Therapy forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

15.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: UPH's forecast earnings growth (15.2% per year) is above the savings rate (0.2%).

Earnings vs Market: UPH's earnings (15.2% per year) are forecast to grow faster than the German market (12.8% per year).

High Growth Earnings: UPH's earnings are forecast to grow, but not significantly.

Revenue vs Market: UPH's revenue (6.3% per year) is forecast to grow faster than the German market (4.8% per year).

High Growth Revenue: UPH's revenue (6.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: UPH's Return on Equity is forecast to be low in 3 years time (11.8%).


Next Steps

Past Performance

How has U.S. Physical Therapy performed over the past 5 years?

2.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UPH has high quality earnings.

Growing Profit Margin: UPH's current net profit margins (6.3%) are higher than last year (4.2%).


Past Earnings Growth Analysis

Earnings Trend: UPH's earnings have grown by 2.5% per year over the past 5 years.

Accelerating Growth: UPH's earnings growth over the past year (61.8%) exceeds its 5-year average (2.5% per year).

Earnings vs Industry: UPH earnings growth over the past year (61.8%) exceeded the Healthcare industry 12.6%.


Return on Equity

High ROE: UPH's Return on Equity (15.6%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is U.S. Physical Therapy's financial position?


Financial Position Analysis

Short Term Liabilities: UPH's short term assets ($92.5M) exceeds its short term liabilities ($62.8M)

Long Term Liabilities: UPH's short term assets ($92.5M) do not cover its long term liabilities (125.3M)


Debt to Equity History and Analysis

Debt Level: UPH's debt to equity ratio (14.9%) is considered satisfactory.

Reducing Debt: UPH's debt to equity ratio has reduced from 27.9% to 14.9% over the past 5 years.

Debt Coverage: UPH's debt is well covered by operating cash flow (116.9%).

Interest Coverage: UPH's interest payments on its debt are well covered by EBIT (36.4x coverage).


Balance Sheet

Inventory Level: UPH has a low level of unsold assets or inventory.

Debt Coverage by Assets: UPH's debt is covered by short term assets (assets are 1.7x debt).


Next Steps

Dividend

What is U.S. Physical Therapy's current dividend yield, its reliability and sustainability?

1.03%

Current Dividend Yield


Dividend Yield vs Market

company1.0%marketbottom25%1.4%markettop25%3.7%industryaverage1.8%forecastin3Years1.1%

Current dividend yield vs market & industry

Notable Dividend: UPH's dividend (1.03%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.4%).

High Dividend: UPH's dividend (1.03%) is low compared to the top 25% of dividend payers in the German market (3.73%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, UPH has been paying a dividend for less than 10 years.

Growing Dividend: UPH's dividend payments have increased, but the company has only paid a dividend for 9 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (45.9%), UPH's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: UPH's dividends in 3 years are forecast to be well covered by earnings (40.5% payout ratio).


Next Steps

Management

What is the CEO of U.S. Physical Therapy's salary, the management and board of directors tenure and is there insider trading?

14.8yrs

Average management tenure


CEO

Chris Reading (55yo)

15yrs

Tenure

US$3,327,384

Compensation

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at  ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD3.33M) is above average for companies of similar size in the German market ($USD1.56M).

Compensation vs Earnings: Chris's compensation has increased by more than 20% in the past year.


Management Age and Tenure

14.8yrs

Average Tenure

58.5yo

Average Age

Experienced Management: UPH's management team is seasoned and experienced (14.8 years average tenure).


Board Age and Tenure

13.2yrs

Average Tenure

67yo

Average Age

Experienced Board: UPH's board of directors are seasoned and experienced ( 13.2 years average tenure).


Insider Trading

Insider Buying: UPH insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$254,40513 Nov 19
Harry Chapman
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares2,400
Max PriceUS$106.00
SellUS$852,65919 Aug 19
Christopher Reading
EntityIndividual
Role
Chief Executive Officer
President
Shares7,000
Max PriceUS$122.04
SellUS$364,54419 Aug 19
Mark Brookner
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,000
Max PriceUS$123.02
SellUS$602,30815 Aug 19
Jerald Pullins
EntityIndividual
Role
Chairman of the Board
Independent Chairman of the Board
Shares5,000
Max PriceUS$120.46
SellUS$603,72615 Aug 19
Glenn McDowell
EntityIndividual
Role
Chief Operating Officer
Chief Operating Officer of West
Shares5,000
Max PriceUS$120.75
SellUS$452,97114 Aug 19
Clayton Trier
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,750
Max PriceUS$120.79
SellUS$113,65013 Aug 19
Graham Reeve
EntityIndividual
Role
Senior Key Executive
Chief Operating Officer of East
Shares952
Max PriceUS$119.38
SellUS$293,08212 Aug 19
Lawrance McAfee
EntityIndividual
Role
Member of the Board of Directors
Executive VP
Shares2,500
Max PriceUS$118.15
SellUS$2,123,28122 May 19
Christopher Reading
EntityIndividual
Role
Chief Executive Officer
President
Shares19,860
Max PriceUS$107.95
SellUS$338,67408 May 19
Mark Brookner
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,250
Max PriceUS$104.25
SellUS$261,00706 May 19
Lawrance McAfee
EntityIndividual
Role
Member of the Board of Directors
Executive VP
Shares2,500
Max PriceUS$104.40
SellUS$180,14106 May 19
Edward Kuntz
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,750
Max PriceUS$102.94
SellUS$323,11506 May 19
Mark Brookner
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,125
Max PriceUS$103.41
BuyUS$46,85301 Apr 19
Kathleen Gilmartin
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares500
Max PriceUS$93.71
BuyUS$88,27620 Mar 19
Harry Chapman
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares950
Max PriceUS$92.92
SellUS$586,90818 Mar 19
Glenn McDowell
EntityIndividual
Role
Chief Operating Officer
Chief Operating Officer of West
Shares6,204
Max PriceUS$99.23
SellUS$298,17511 Mar 19
Lawrance McAfee
EntityIndividual
Role
Member of the Board of Directors
Executive VP
Shares3,150
Max PriceUS$94.66
BuyUS$44,33827 Dec 18
Reginald Swanson
EntityIndividual
Role
Member of the Board of Directors
Director
Shares500
Max PriceUS$88.70
BuyUS$117,30013 Dec 18
Harry Chapman
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,200
Max PriceUS$97.75

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Rick Binstein

    Secretary

    • Tenure: 0yrs
  • Larry McAfee (64yo)

    Executive VP

    • Tenure: 15yrs
    • Compensation: US$1.88m
  • Chris Reading (55yo)

    President

    • Tenure: 15yrs
    • Compensation: US$3.33m
  • Glenn McDowell (62yo)

    Chief Operating Officer of West

    • Tenure: 14.8yrs
    • Compensation: US$1.88m
  • Jon Bates

    VP & Corporate Controller

    • Tenure: 13yrs
  • Graham Reeve (55yo)

    Chief Operating Officer of East

    • Tenure: 1.7yrs
    • Compensation: US$1.95m
  • Johnny Blanchard

    Assistant Controller

    • Tenure: 0yrs

Board Members

  • Eddie Kuntz (74yo)

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: US$266.45k
  • Mark Brookner (74yo)

    Independent Director

    • Tenure: 21.3yrs
    • Compensation: US$252.70k
  • Larry McAfee (64yo)

    Executive VP

    • Tenure: 15yrs
    • Compensation: US$1.88m
  • Clayton Trier (67yo)

    Independent Director

    • Tenure: 14.8yrs
    • Compensation: US$268.20k
  • Bernard Harris (62yo)

    Independent Director

    • Tenure: 14.3yrs
    • Compensation: US$255.20k
  • Chris Reading (55yo)

    President

    • Tenure: 15yrs
    • Compensation: US$3.33m
  • Jerry Pullins (77yo)

    Independent Chairman of the Board

    • Tenure: 8.5yrs
    • Compensation: US$316.45k
  • Kathleen Gilmartin (67yo)

    Independent Director

    • Tenure: 1.5yrs
    • Compensation: US$215.83k
  • Regg Swanson (65yo)

    Director

    • Tenure: 12.2yrs
    • Compensation: US$299.37k
  • Harry Chapman (74yo)

    Independent Director

    • Tenure: 9.3yrs
    • Compensation: US$268.70k

Company Information

U.S. Physical Therapy, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: U.S. Physical Therapy, Inc.
  • Ticker: UPH
  • Exchange: DB
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$1.486b
  • Listing Market Cap: US$1.347b
  • Shares outstanding: 12.77m
  • Website: https://www.usph.com

Number of Employees


Location

  • U.S. Physical Therapy, Inc.
  • 1300 West Sam Houston Parkway South
  • Suite 300
  • Houston
  • Texas
  • 77042
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
USPHNYSE (New York Stock Exchange)YesCommon StockUSUSDMay 1992
UPHDB (Deutsche Boerse AG)YesCommon StockDEEURMay 1992

Biography

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related i ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/22 21:34
End of Day Share Price2019/11/22 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.